CBC Continues Strong Momentum and Reaches Major Milestones Across Healthcare Investment Platforms
09/15/20, 2:32 AM
Location
shanghai
CBC Group ("CBC"), a healthcare-dedicated investment firm, announced three major milestones across three of its healthcare investment platforms in September, underscoring CBC's strong momentum amid an evolving market. This includes NiKang Therapeutics' ("NiKang") US$50 million Series B financing, I-Mab's US$3 billion partnership with AbbVie and US$418 million private placement agreement and Lu Daopei Medical Group's over RMB100 million (approximately US$14.6 million) Series B+ funding round.
Company Info
Location
shanghai, shanghai, china
Additional Info
CBC Group (formerly C-Bridge Capital) is one of the largest and most active healthcare-dedicated investment firms in Asia focused on platform-building and buyout opportunities across three core areas within the healthcare sector: pharmaceutical & biotech, medtech and healthcare services. CBC's operationally intensive approach empowers healthcare sector champions to make transformative changes to enable sustainable long-term growth, fulfill unmet medical needs and continuously improve the standard of living and quality of care in China and the rest of Asia. Founded in 2014, CBC has a strong team of investment, healthcare and portfolio management professionals based across Singapore, Shanghai, Beijing, Hong Kong and New York. For more information, please visit www.cbridgecap.com.